Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does ASPIRIN DL-LYSINE Cause Visual acuity reduced? 5 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 5 reports of Visual acuity reduced have been filed in association with ASPIRIN DL-LYSINE. This represents 0.1% of all adverse event reports for ASPIRIN DL-LYSINE.

5
Reports of Visual acuity reduced with ASPIRIN DL-LYSINE
0.1%
of all ASPIRIN DL-LYSINE reports
0
Deaths
1
Hospitalizations

How Dangerous Is Visual acuity reduced From ASPIRIN DL-LYSINE?

Of the 5 reports, 1 (20.0%) required hospitalization, and 1 (20.0%) were considered life-threatening.

Is Visual acuity reduced Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for ASPIRIN DL-LYSINE. However, 5 reports have been filed with the FAERS database.

What Other Side Effects Does ASPIRIN DL-LYSINE Cause?

Acute kidney injury (658) Anaemia (469) Lactic acidosis (312) Hyperkalaemia (246) Interstitial lung disease (225) Cerebral haemorrhage (219) Fall (218) Melaena (200) Thrombocytopenia (189) Diarrhoea (180)

What Other Drugs Cause Visual acuity reduced?

RANIBIZUMAB (1,342) INSULIN LISPRO (1,172) AFLIBERCEPT (993) BELANTAMAB MAFODOTIN (708) BEVACIZUMAB (451) DIMETHYL (440) INSULIN GLARGINE (438) INTERFERON BETA-1A (396) INSULIN HUMAN (393) BROLUCIZUMAB-DBLL (365)

Which ASPIRIN DL-LYSINE Alternatives Have Lower Visual acuity reduced Risk?

ASPIRIN DL-LYSINE vs ASPIRIN LYSINE ASPIRIN DL-LYSINE vs ASPIRIN\BUTALBITAL\CAFFEINE ASPIRIN DL-LYSINE vs ASPIRIN\CAFFEINE ASPIRIN DL-LYSINE vs ASPIRIN\CARISOPRODOL ASPIRIN DL-LYSINE vs ASPIRIN\CARISOPRODOL\CODEINE

Related Pages

ASPIRIN DL-LYSINE Full Profile All Visual acuity reduced Reports All Drugs Causing Visual acuity reduced ASPIRIN DL-LYSINE Demographics